Tyler Dylan-Hyde, Chief Legal Officer at CRISPR Therapeutics AG (CRSP), sold 37,230 shares at $23.76 ($840K) on 2017-12-29, disclosed to the SEC on 2018-01-02.
Open-market sale of $840k CRSP by Chief Legal Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $21.75 | 700 | $15K | 1.8% |
| 2 | $21.75 | 1,070 | $23K | 2.8% |
| 3 | $21.75 | 6,230 | $136K | 16.1% |
| 4 | $21.75 | 6,230 | $136K | 16.1% |
| 5 | $22.68 | 15,000 | $340K | 40.5% |
| 6 | $23.76 | 8,000 |
| $190K |
| 22.6% |
| Total | $22.56 avg | 37,230 | $840K | 100% |
| Filing → |
| CRSP | SELL | 2017-12-27 | $308K | — | Filing → |
| CRSP | SELL | 2017-12-19 | $284K | — | Filing → |
| CRSP | SELL | 2017-08-08 | $524K | — | Filing → |